NCT06746506

Brief Summary

This study was planned to determine the effect of therapeutic play with amigurumi toys on pain and fear during blood collection in children aged 4 to 6 years who applied to the pediatric emergency department. The project is a randomized controlled trial. The study covers children aged 4-6 years who came to the blood collection unit of the pediatric emergency department of Recep Tayyip Erdoğan University Education and Research Hospital between January and June 2025. The research sample will consist of children who applied to the unit on the specified dates, met the research criteria, and volunteered to participate in the study. The "Survey Form", "Wong-Baker Facial Expression Assessment Scale" and "Child Fear Scale" will be used to collect data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 24, 2024

Completed
8 days until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

October 8, 2025

Status Verified

October 1, 2025

Enrollment Period

6 months

First QC Date

December 17, 2024

Last Update Submit

October 2, 2025

Conditions

Keywords

bloodlettingfearpainchildrenamigurumi toy

Outcome Measures

Primary Outcomes (2)

  • Wong-Baker Facial Expression Evaluation Scale

    The scale was developed in 1981 and was revised in 1983. The scale is used to define pain in the 3-18 age group. The scale indicates that the severity of pain increases from zero to five as you go from left to right. Facial expressions are included under the numbers to describe the severity of pain. It consists of 6 faces in total. While the first smiling facial expression expresses the pain-free state, the crying facial expression at the end indicates the most severe pain intensity. While applying the scale, the child is told to choose the facial expression that best describes his feelings at the moment. Six facial expressions are scored between 0-5 points from left to right (0 points = very happy/no pain, 5 points = indicates the most severe pain). As the score obtained from the scale increases, the pain tolerance decreases, and as the score decreases, the tolerance increases.

    6 months

  • Child Fear Scale

    The scale was developed in 2011. The Child Fear Scale is used to determine the level of fear in children undergoing painful medical procedures. The Child Fear Scale is a scale from 0-4 showing five faces ranging from a neutral expression (0 = no worry) to the feared face (4 = serious anxiety).

    6 months

Study Arms (2)

Amigurumi toy, pain and fear

EXPERIMENTAL
Behavioral: Amigurumi toy

control not pain and fear

NO INTERVENTION

Interventions

Amigurumi toyBEHAVIORAL

A toy prepared using anti-allergic yarn to suit children's developmental stages.

Amigurumi toy, pain and fear

Eligibility Criteria

Age4 Years - 6 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 4-6,
  • Those who applied to the hospital as outpatients due to an acute illness,
  • Those who were rated as yellow triage in the 3-level (red-yellow-green) triage system,
  • Those whose mother or father was with the child during the procedure,
  • Those whose blood was drawn with a single procedure,
  • Those whose health status was stable will be included in the study.

You may not qualify if:

  • \- Children who have a history of sedative, analgesic or narcotic substance use within 24 hours before application,
  • Children with a fever higher than 38 °C,
  • Children with visual, hearing, language development, mental and neurological disorders,
  • Children with a chronic or life-threatening disease,
  • Children who refuse to participate in the study,
  • Children who are treated in the red or green zone according to the triage system (red = critical emergency, requiring immediate action; yellow = unstable condition, requiring intervention within 60 minutes; and green = stable condition, intervention should be performed within 2 hours) will not be included in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Recep Tayyip Erdogan University

Rize, Güneysu, 53350, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 17, 2024

First Posted

December 24, 2024

Study Start

January 1, 2025

Primary Completion

June 30, 2025

Study Completion

October 1, 2025

Last Updated

October 8, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

The aim is to share the research after it is published.

Locations